This randomized controlled trial aims to evaluate the effect of nurse-led telehealth monitoring on medication adherence, self-efficacy, and quality of life in individuals with inflammatory bowel disease (IBD). The study will be conducted at the IBD Outpatient Clinic of Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty. Participants will be randomly assigned to either an intervention group receiving a 3-month structured telehealth program (including education, counseling, phone calls, and reminders) or a control group receiving only standard care and an educational booklet. Outcomes will be assessed at baseline and after 12 weeks.
Individuals aged 18 years or older
Individuals aged 18 years or older
Able to read and write in Turkish
Diagnosed with inflammatory bowel disease (IBD) for at least 6 months
Diagnosed with any psychiatric or cognitive disorder
Having any condition that impairs communication
Pregnant women
Patients receiving infusion-based treatment